0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035 - Product Thumbnail Image

Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035

  • Report
  • March 2025
  • 245 Pages
  • Global
From
EUR$6,061USDGBP
NASH Market Outlook 2037 - Product Thumbnail Image

NASH Market Outlook 2037

  • Report
  • November 2024
  • 223 Pages
  • Global
From
EUR$5,550USDGBP
Liver Disease Treatments Market - Product Thumbnail Image

Liver Disease Treatments Market

  • Report
  • April 2025
  • 164 Pages
  • Global
From
EUR$3,255USDGBP
EUR$4,650USDGBP
Alagille Syndrome Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035 - Product Thumbnail Image

Alagille Syndrome Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035

  • Report
  • May 2025
  • Global
From
EUR$4,900USDGBP
Acute On Chronic Liver Failure Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035 - Product Thumbnail Image

Acute On Chronic Liver Failure Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • May 2025
  • Global
From
EUR$4,900USDGBP
Chronic Hepatitis B Market - A Global and Regional Analysis: Focus on Regional Analysis - Analysis and Forecast, 2025-2035 - Product Thumbnail Image

Chronic Hepatitis B Market - A Global and Regional Analysis: Focus on Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • May 2025
  • Global
From
EUR$4,900USDGBP
Diabetic nephropathy Market by Therapeutic Agents, Diagnostic Solutions, Distribution Channel, End User, Stage of Disease, Route of Administration - Global Forecast to 2030 - Product Thumbnail Image

Diabetic nephropathy Market by Therapeutic Agents, Diagnostic Solutions, Distribution Channel, End User, Stage of Disease, Route of Administration - Global Forecast to 2030

  • Report
  • May 2025
  • 193 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Milk Thistle Products Market by Form, Distribution Channel, Application, End User - Global Forecast to 2030 - Product Thumbnail Image

Milk Thistle Products Market by Form, Distribution Channel, Application, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 194 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Erythropoietin Stimulating Agents Market by Product Type, Indication, Route of Administration, Distribution Channel, End User - Global Forecast to 2030 - Product Thumbnail Image

Erythropoietin Stimulating Agents Market by Product Type, Indication, Route of Administration, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 183 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Hepatitis Therapeutics Market by Therapeutic Class, Genotype, Route of Administration, Distribution Channel, Stage of Disease - Global Forecast to 2030 - Product Thumbnail Image

Hepatitis Therapeutics Market by Therapeutic Class, Genotype, Route of Administration, Distribution Channel, Stage of Disease - Global Forecast to 2030

  • Report
  • May 2025
  • 180 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Chronic Kidney Disease Market by Therapy Type, Disease Stage, End User, Product, Patient Type - Global Forecast to 2030 - Product Thumbnail Image

Chronic Kidney Disease Market by Therapy Type, Disease Stage, End User, Product, Patient Type - Global Forecast to 2030

  • Report
  • May 2025
  • 186 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Potassium Citrate Market by Application, Form, Distribution Channel - Global Forecast to 2030 - Product Thumbnail Image

Potassium Citrate Market by Application, Form, Distribution Channel - Global Forecast to 2030

  • Report
  • May 2025
  • 186 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Hepatorenal Syndrome Treatment Market by Treatment Type, Patient Severity, Route of Administration, End User, Distribution Channel, Product Type - Global Forecast to 2030 - Product Thumbnail Image

Hepatorenal Syndrome Treatment Market by Treatment Type, Patient Severity, Route of Administration, End User, Distribution Channel, Product Type - Global Forecast to 2030

  • Report
  • May 2025
  • 185 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
End Stage Renal Disease Market by Treatment Modality, End User, Access Type - Global Forecast to 2030 - Product Thumbnail Image

End Stage Renal Disease Market by Treatment Modality, End User, Access Type - Global Forecast to 2030

  • Report
  • May 2025
  • 199 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Liver Fibrosis Drugs Market by Drug Class, Mechanism of Action, Route of Administration, Distribution Channel - Global Forecast to 2030 - Product Thumbnail Image

Liver Fibrosis Drugs Market by Drug Class, Mechanism of Action, Route of Administration, Distribution Channel - Global Forecast to 2030

  • Report
  • May 2025
  • 198 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Liver Diseases Therapeutics Market by Disease Type, Therapy Type, Drug Class, Route of Administration, Distribution Channel, End User - Global Forecast to 2030 - Product Thumbnail Image

Liver Diseases Therapeutics Market by Disease Type, Therapy Type, Drug Class, Route of Administration, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 191 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Osteobiologics Market by Allografts, Bone Morphogenetic Protein, Synthetic Grafts, Demineralized Bone Matrix, Ceramic Grafts, Cell Based Grafts - Global Forecast to 2030 - Product Thumbnail Image

Osteobiologics Market by Allografts, Bone Morphogenetic Protein, Synthetic Grafts, Demineralized Bone Matrix, Ceramic Grafts, Cell Based Grafts - Global Forecast to 2030

  • Report
  • May 2025
  • 188 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Digital Platform for Renal Care Market by Component, Deployment Mode, Delivery Model, Application, End User, Therapeutic Stage, Integration Level - Global Forecast to 2030 - Product Thumbnail Image

Digital Platform for Renal Care Market by Component, Deployment Mode, Delivery Model, Application, End User, Therapeutic Stage, Integration Level - Global Forecast to 2030

  • Report
  • May 2025
  • 196 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Progressive Familial Intrahepatic Cholestasis Treatment Market by Treatment Type, Drug Class, End User, Distribution Channel, Route Of Administration, Patient Age Group, Pfic Type - Global Forecast to 2030 - Product Thumbnail Image

Progressive Familial Intrahepatic Cholestasis Treatment Market by Treatment Type, Drug Class, End User, Distribution Channel, Route Of Administration, Patient Age Group, Pfic Type - Global Forecast to 2030

  • Report
  • May 2025
  • 199 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Diabetic Nephropathy Treatment Market by Treatment Type, Distribution Channel, Route Of Administration, Disease Stage, Patient Population - Global Forecast to 2030 - Product Thumbnail Image

Diabetic Nephropathy Treatment Market by Treatment Type, Distribution Channel, Route Of Administration, Disease Stage, Patient Population - Global Forecast to 2030

  • Report
  • May 2025
  • 190 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more